Behavioral Health Clinical Trials

Clinical trials provide a valuable way to study the effects of new medications or treatments and how they impact people. For example, when developing a vaccine, clinical trials will be conducted to learn as much as possible about the vaccine, how it works, its long-term effects, and to glean other relevant data. When enough information is gathered to deduce that the vaccine is safe for human use, then it will gain approval for sale and use.

Clinical trials contribute greatly to the field of mental health care. Countless medications have been developed to help treat symptoms associated with a variety of different mental health conditions. Through clinical trials, these medications were tested and perfected so that millions of people who struggle with mental illness can benefit from taking them.

If you are interested in participating in a clinical trial, it can be a rewarding experience. You will be contributing to the future of mental health care and helping medical experts determine what medications can help change the lives of others. In many cases, you will receive some type of compensation for your participation. Read more to understand how clinical trials work and what types are available.

Clinical trials help test the safety and efficiency of new treatments in a controlled manner with volunteer members. For any newly developed drug or treatment method designed to provide treatment for conditions like mental illness, clinical trials are used. These trials enhance the quality of the medication, provide a full spectrum of knowledge about them to medical professionals, and improve levels of patient care. Many volunteers benefit from receiving advanced new treatments before they become publicly available.

Neuroscience Institute is a leader in clinical trials research in South Florida, Palm Beach County, and West Palm Beach. We conduct Phase I-IV clinical trials for pharmaceutical companies, contract research organizations (CROs), biotechnology companies, and other research organizations. We provide high-quality psychiatric clinical trials, along with ethical care and innovative treatment, which meet the medical, scientific, and professional needs of clients and sponsors.

Neuroscience Institute employs a dedicated team of highly qualified researchers who conduct our clinical trials. Our diverse team consists of psychiatrists, multi-specialty physicians, psychologists, pharmacists, nurses, social workers, clinical research coordinators, and other support staff. Our staff has over 17 years of clinical trials experience in both academic and non-academic settings. They understand how to safely implement efficacy studies in both outpatient and inpatient facilities.

Outpatient Treatment

Behavioral Health Clinical Studies

Most recently these mental health clinical trials have been conducted:

  • Adult ADHD clinical trial
  • Adult Depression study
  • Adult Bipolar study clinical trial
  • Early Onset Alzheimer’s clinical trial
  • Depression with suicidal ideation clinical trial
  • Dementia with Hallucinations and Delusions clinical trial

Clinical Trial Studies Available Now

If you are interested in getting more information about our clinical trials, please reach out to our team at Neuroscience Institute at

(888) 492-1633 to speak with a specialist today.

Ting Ting Duan, PhD

Clinical Research Coordinator

Alexia Medick

Clinical Trials Coordinator

Clinical Trial Sponsors

Major Pharmaceutical Sponsors:

  •  MERCK

Contract Research Organizations (CROs):

  •  ICON

Clinical Trials Research


  • Substance Use Disorders
    • Alcohol Use Disorders
    • Opiate Use Disorders
    • Cocaine Use Disorders
    • Methamphetamine Use Disorders
  • Anxiety Disorder
  • Attention Deficit Disorder
  • Bipolar Depression
  • Bipolar Mania / Hypomania
  • Depression in Aging
  • Depression, Treatment Resistant
  • Depressive Disorders
  • Dysthymia
  • Generalized Anxiety Disorder
  • Impotence
  • Insomnia / Sleep Disorder
  • Major Depression
  • Mood Disorders with Pain Syndromes
  • Obesity
  • Obsessive / Compulsive Disorder
  • Panic Disorder
  • Pharmacokinetics, Mental Disorders
  • Pharmacokinetics, Schizophrenia and Related Psychotic Disorders
  • Post-Traumatic Stress Disorder
  • Psychoactive Substance Use Disorder· Psychosis
  • Psychosis in Dementia
  • Schizophrenia / Schizoaffective Disorder
  • Schizophrenia, Treatment Resistant
  • Seasonal Affective Disorder· Sexual Disorders
  • Social Phobia

Why Volunteer For A Mental Health Clinical Trial?

The development of a new drug is a long and complicated journey. Most of the drugs in use today have, after their initial discovery, undergone a range of laboratory tests using cell cultures, isolated tissues, and animals. If a drug shows clinical potential, it may be used in humans only after successful testing is completed. Of the approximately 50,000 medications synthesized in a laboratory, only about five will reach the stage of full tests in humans. Only one of these will actually be safe and effective enough to be put on the market.

Volunteering for clinical trials allows a person to help contribute to the development of medications and treatments that can potentially change the lives of millions of people. Advances in medications allow people to manage medical and psychological side effects of illnesses or cure the conditions completely. Many volunteers enjoy contributing to the advancement of medical care. In fact, participants often receive care not yet available on the market which can result in improving their own health.

The tests on humans can generally be classified into four phases:

Phase I

These are normally done with healthy volunteers, usually in special hospital units equipped for performing these trials. Studies on the drug’s absorption, distribution, metabolism, and excretion (pharmacokinetics) are done.

Phase II

These are generally the first trials in patients, conducted to mainly give an idea of efficacy, to identify the optimal dose, and to provide the first indication on safety in patients. Up to a few hundred patients are involved in this phase.

Phase III

These involve the main assessments of the safety and efficacy of a drug. Several thousands of patients are often treated in this phase.

Phase IV

These are performed after obtaining a license to market the drug. Contrary to Phases II and III, problems associated with long-term use of the drug or rare adverse events can be detected.

There are two basic principles of GCP. The first involves protecting the research patient or volunteer. The second involves collecting accurate data that can be replicated. One of the reasons that GCP was introduced and accepted was because of concern about drug safety. In particular, there was public anxiety among regulators about the quality and reliability of the research data submitted to regulatory authorities. Fraudulent data could jeopardize patient safety or cause rejection of an application for a new drug with the potential for curing illness. Fraudulent data usually emphasized the efficacy and underplayed the toxicity of a drug. GCP helps address and eliminate these risks.

Pharmaceutical companies around the world are engaged in more research now than ever before in the history of medicine. It is through the research process that new treatments are discovered to treat illnesses that might otherwise be incurable or unmanageable. Without research, many diseases that have been controlled or have been cured would still plague the world.

Various government agencies are charged with regulating medications, medical devices, and medical treatments. The primary goals of this regulation are to make sure that the medications available in the United States are both safe and effective in the treatment of particular illnesses. Clinical trial research tests the use of medications that are currently available by prescription and investigates the possibility of medications being made available without a prescription. This improves safety for patients and can expand the number of people who have access to needed medications. Research also looks at the cost of medications and the worth of the expense to society.

Research is done by a variety of different organizations and groups. The National Institutes of Health, the Food and Drug Administration (FDA), private foundations, and pharmaceutical companies are some of the groups that perform clinical trials. Other branches of industry and government may request or sponsor research. Universities, government agencies, and research centers are common research settings for clinical trials.

All participants in clinical trials are volunteers and chosen for different reasons, depending on the study. Some types of studies require participants who are healthy and not suffering from any current illnesses. These studies are largely for the purpose of investigating the metabolism of a drug.

For most studies, participants must be diagnosed with a specific illness or disease. A physician or other licensed professionals will take a detailed history, perform a physical examination, and review laboratory tests to make sure that the diagnosis is correct. They will also ensure that no other illness will confound the results of the study or endanger the patient’s health or safety.

Volunteers come to the clinic from a variety of sources, including referrals from physicians, hospitals, and previous study participants. They may also be chosen from their response to an advertisement or other public notices.

Before a medication or treatment can be used in general medical practice, it has to be proven to be safe in a laboratory or research clinic setting. Before a volunteer begins participation in a research study, the potential risks and side effects of the experimental medication are explained to them in detail. The participant signs a consent form that reviews the study design, and the safety and efficacy profile of the medication being studied. The research itself is conducted under the supervision of a physician and their staff, and a medical monitor from the sponsoring agency, organization, or pharmaceutical company.

All participants in a clinical research study have a medical chart at the research company. This includes the results of the initial history and physical examination, laboratory tests, cardiograms, and the results of any other medical procedures. Upon request, these records can be sent to your own physician for inclusion in your permanent record.

For each study, a copy of the experimental protocol and complete information about the medication is reviewed by an independent Institutional Review Board (IRB) member or ethics committee. No volunteers can be entered into a research study before a committee has approved of the research protocol, the advertisements for the research, and the consent form that explains the research to the participant.

Payment for participation in clinical trials varies according to the research project, medication, disease under investigation, and phase in the development cycle of the study. Often the cost of transportation will be reimbursed. For phase I and early phase II studies, where there are no long-term therapeutic benefits to participants, often compensation is given for the time involved, and any discomfort caused by the experimental procedures. Discussion and agreement upon any monetary or other types of payment for participation in all phases will be discussed before beginning a clinical trial.

For a medication to be shown effective, it has to be compared with an inactive substance or placebo medication. If the medication is no better than the placebo, the conclusion from the research is that it doesn’t work. In addition, experimental medications are often compared against a marketed compound. To be a useful medication, it should be as effective as a medication currently on the market and better than a placebo. Interestingly, 30-40% of volunteers who take placebo medication get relief from their symptoms.

Volunteers sometimes are diagnosed with an illness or disease at the end of their participation. When this happens, follow-up medical care is often provided, including follow-up visits with the physician or someone on their staff, and in some cases, medication for three months. We then refer patients back to their regular physicians with recommendations for treatment.

Informed consent is the process designed to give volunteers the information that they need to decide about participating in a clinical study. This process allows the volunteer to ask questions and to exchange information freely with the clinical investigator. The clinical investigator is responsible for ensuring that informed consent is obtained from each volunteer before that person participates in the research study.

The IRB is a group of healthcare professionals and non-scientific members which must review and approve a clinical study before it begins. The IRB carefully reviews study activities because its primary responsibility is to protect the safety and rights of participants.

Online Resources

Addiction Treatment in Singer Island, FL

Clinical Trials in West Palm Beach, FL

Clinical research trials are crucial to advancing medical treatment for mental illnesses and many other conditions. The trials rely on the generosity of clinical research trials are crucial to advancing medical treatment for mental illnesses and many other conditions. The trials rely on the generosity of volunteers who are willing to help provide input through their experiences as research study members. If you are interested in participating in a clinical trial, please reach out to our staff and we can answer any questions you have. Call Neuroscience Institute today at  (888) 492-1633.

We Accept Most Insurances

Table of Contents
Scroll to Top